GGrantIndex
← Leaderboards

Angeliki Louvi

Yale University

$5,638,407
Attributed
$9,875,758
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,875,758 · 7

By mechanism

R01$8,563,017 · 4
R21$1,312,741 · 3

Top collaborators

Most similar at Yale University

Same institution · by research overlap

Others in their field

Top investigators on “Mediating

Research focus

MediatingAffectPathway InteractionsMouse ModelGenesMolecularAnimal ModelGeneticValidationBrainIn VivoPhenotypeFutureAdultEventEmbryoCandidate Disease GeneGenome EditingEtiologyCell TypeBlood VesselsBrain HemorrhageIn VitroBiological

Grant awards (21)

A Gene-Network Discovery Approach to Structural Brain Disorders$645,930
R01 · FY2025 · HD · contact PI
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm$589,159
R01 · FY2025 · NS
A Gene-Network Discovery Approach to Structural Brain Disorders$675,429
R01 · FY2024 · HD · contact PI
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm$644,585
R01 · FY2024 · NS
A Gene-Network Discovery Approach to Structural Brain Disorders$684,946
R01 · FY2023 · HD · contact PI
Functional Validation of Intracranial Aneurysm Risk Genes$605,771
R01 · FY2023 · NS
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm$603,005
R01 · FY2023 · NS
Functional Validation of Intracranial Aneurysm Risk Genes$608,534
R01 · FY2022 · NS
Brain Cholesterol Biosynthesis in Health and Neurological Disease$460,625
R21 · FY2022 · NS · contact PI
Functional Validation of Intracranial Aneurysm Risk Genes$605,997
R01 · FY2021 · NS
Functional Validation of Intracranial Aneurysm Risk Genes$603,007
R01 · FY2020 · NS
Functional Validation of Intracranial Aneurysm Risk Genes$591,240
R01 · FY2019 · NS
Candidate Pharmacological Therapies for Cerebral Carvernous Malformations$209,375
R21 · FY2019 · NS · contact PI
Candidate Pharmacological Therapies for Cerebral Carvernous Malformations$251,250
R21 · FY2018 · NS · contact PI
Molecular Mechanisms of Primary Microcephaly$345,488
R01 · FY2017 · HD · contact PI
Molecular Mechanisms of Primary Microcephaly$342,033
R01 · FY2016 · HD · contact PI
Molecular Mechanisms of Primary Microcephaly$336,850
R01 · FY2015 · HD · contact PI
Molecular Mechanisms of Primary Microcephaly$335,814
R01 · FY2014 · HD · contact PI
Molecular Mechanisms of Primary Microcephaly$345,229
R01 · FY2013 · HD · contact PI
Development of Choroid Plexus and the Blood-CSF Barrier$184,605
R21 · FY2006 · NS · contact PI
Development of Choroid Plexus and the Blood-CSF Barrier$206,886
R21 · FY2005 · NS